The groundbreaking success of Viagra undeniably revolutionized the drug landscape, but investing in companies strongly reliant on off-patent versions presents a complex picture. Although early profits were impressive, the cessation of patents and the appearance of cheaper alternatives have eroded the customer base. Thus, a thorough analysis of ongo